title: [New routes of administration: epidermal, transcutaneous mucosal ways of vaccination].
abstract: A successful vaccine triggers the interaction of various cells of the immune system as does a regular immune response. It is thus necessary to introduce the vaccine antigens into an anatomic site where they will contact immune cells. The route of administration is thus critical for the outcome of vaccination. Intramuscular or subcutaneous injections are the most popular. Antigens injected intramuscularly can form persistent precipitates that are dissolved and re-absorbed relatively slowly. If injecting antigens is a quick, easy and reproducible way to vaccination, it requires trained personnel. Alternatives exist, through non-invasive formulations which allow administration by the patient or a third party with no particular expertise. The skin, especially its epidermal layer, is an accessible and competent immune environment and an attractive target for vaccine delivery, through transcutaneous delivery or immunostimulant patches. Mucosal immunization is another strategy: its major rationale is that organisms invade the body via mucosal surfaces. Therefore, local protection at mucosal surface as well as systemic defense is beneficial. Various formulations of mucosal vaccines have been developed, such as the Sabin oral polio vaccine (OPV), rotavirus vaccines, cold-adapted influenza vaccines or vaccine against typhoid fever. Thus we are entering in an era where mucosal and transcutaneous immunisation will play an important role in disease management. However, it has not been so easy to obtain regulatory approval for mucosal or transcutaneous formulations and needle-based vaccines continue to dominate the market.
authors: Laboratoire de Bactériologie-Virologie-Hygiène, EA 3175, CHU Dupuytren, 2, avenue Martin Luther King, 87042 Limoges Cedex, France. francois.denis@unilim.fr
authors: François
authors: F
authors: Denis
authors: Sophie
authors: S
authors: Alain
authors: Marie-Cécile
authors: MC
authors: Ploy
mesh_terms: D000279:Administration, Cutaneous; D000281:Administration, Intranasal; D000284:Administration, Oral; D000285:Administration, Rectal; D000328:Adult; D000336:Aerosols; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000276:immunology / Q000493:pharmacokinetics; D002648:Child; D004333:Drug Administration Routes; D006801:Humans; D018928:Immunity, Mucosal; D007279:Injections, Subcutaneous; D014611:Vaccination / Q000379:methods*; D014612:Vaccines / Q000008:administration & dosage* / Q000493:pharmacokinetics; D014765:Viral Vaccines / Q000008:administration & dosage / Q000276:immunology / Q000493:pharmacokinetics
chemical_list: D000336:Aerosols; D001428:Bacterial Vaccines; D014612:Vaccines; D014765:Viral Vaccines